UPM Pharmaceuticals Inc., a Baltimore-based drug development and contract manufacturer, said it will acquire a 500,000-square-foot commercial manufacturing facility in Bristol, Tenn., that is owned and operated by Pfizer Inc.Read More »
TRENTON, N.J. — Drugmaker Pfizer Inc. expects to pay about $825 million to resolve government and civil lawsuits involving numerous medicines, according to a filing with regulators. The quarterly Securities and Exchange Commission filing made Friday, in a 15-page section ...Read More »
How would your company deal with a situation in which a general counsel had a financial conflict of interest?
Tagged with: company conflict-of-interest cvs ethics fannie mae general counsel in-house counsel In-House Interrogatory in-house interrogatory lawyer National Labor Relations Board pfizer politics social media stock Wal-mart workRead More »
NEW YORK — The Dow Jones industrial average is dumping Cool Whip for copays. The Dow, perhaps the most widely known barometer of the U.S. stock market, announced Friday that it would boot Kraft Foods to make room for UnitedHealth ...
Tagged with: american international group Bank of America cisco citigroup dow dow jones industrial average general electric general motors google hewlett-packard ibm Insurance investors kraft foods merck pfizer san francisco stock market Stocks StocksRead More »
TRENTON, N.J. — If brand-name prescription medicines cost you as little as generic pills, which would you choose? A few drugmakers are betting Americans will stick with the name they know. They’ve begun offering U.S. patients coupons to reduce copayments ...Read More »
WASHINGTON — Pfizer has agreed to pay the federal government $60 million to settle allegations that its employees bribed doctors and other foreign officials in Europe and Asia to win business and boost sales. The Securities and Exchange Commission said ...Read More »
NEW YORK — Pfizer Inc. and Johnson & Johnson said Monday they are ending development of an intravenous formulation of a drug to treat Alzheimer’s disease after the treatment failed in two late-stage clinical trials. The companies said bapineuzumab intravenous ...Read More »
TRENTON, N.J. — Five large drug and grocery chains are suing Pfizer Inc. and a second drugmaker, alleging they conspired to delay sales of cheap generic versions of the blockbuster cholesterol drug Lipitor. Lipitor, the world’s top-selling drug ever, had ...Read More »